Si-Bone (SIBN) Net Margin (2017 - 2026)
Si-Bone's quarterly Net Margin came in at 8.24% in Q1 2026, up 561.0% year-on-year from 1.25% in Q1 2025, and down 182.2% quarter-over-quarter from 2.92% in Q4 2025.
Si-Bone has reported Net Margin for 10 years, with the latest figure at 8.24% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 561.0% year-over-year to 8.24%; the trailing twelve-month figure through Mar 2026 stood at 8.08% (up 697.0% YoY), and the FY2025 full-year result was 9.4%, up 905.0% from the prior year.
- Net Margin for Q1 2026 stood at 8.24%, down from 2.92% in the prior quarter.
- The five-year high for Net Margin was 2.92% in Q4 2025, with the low at 77.35% in Q1 2022.
- Average Net Margin over 5 years is 28.64%, with a median of 28.55% recorded in 2024.
- Year-over-year, Net Margin plunged 1582 bps in 2022 and soared 4311 bps in 2023.
- Tracing SIBN's Net Margin over 5 years: stood at 35.76% in 2022, then increased by 20 bps to 28.74% in 2023, then soared by 68 bps to 9.19% in 2024, then surged by 68 bps to 2.92% in 2025, then plunged by 182 bps to 8.24% in 2026.
- The last three Net Margin figures came in at 8.24% (Q1 2026), 2.92% (Q4 2025), and 9.33% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | -8.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.24% |
| Dec 31, 2025 | -2.92% |
| Sep 30, 2025 | -9.33% |
| Jun 30, 2025 | -12.65% |
| Mar 31, 2025 | -13.85% |
| Dec 31, 2024 | -9.19% |
| Sep 30, 2024 | -16.31% |
| Jun 30, 2024 | -22.37% |
| Mar 31, 2024 | -28.55% |
| Dec 31, 2023 | -28.74% |
| Sep 30, 2023 | -29.04% |
| Jun 30, 2023 | -33.72% |
| Mar 31, 2023 | -34.24% |
| Dec 31, 2022 | -35.76% |
| Sep 30, 2022 | -52.87% |
| Jun 30, 2022 | -71.79% |
| Mar 31, 2022 | -77.35% |
| Dec 31, 2021 | -57.33% |
| Sep 30, 2021 | -70.95% |
| Jun 30, 2021 | -63.05% |
| Mar 31, 2021 | -61.53% |
| Dec 31, 2020 | -40.09% |
| Sep 30, 2020 | -47.05% |
| Jun 30, 2020 | -88.92% |
| Mar 31, 2020 | -75.00% |
| Dec 31, 2019 | -46.58% |
| Sep 30, 2019 | -69.29% |
| Jun 30, 2019 | -53.17% |
| Mar 31, 2019 | -61.94% |
| Dec 31, 2018 | -32.12% |
| Sep 30, 2018 | -31.81% |
| Jun 30, 2018 | -21.21% |
| Mar 31, 2018 | -32.49% |
| Dec 31, 2017 | -35.31% |
| Sep 30, 2017 | -51.36% |